UPL Completes the Acquisition of Arysta LifeScience, Launches its New Purpose: Open Agriculture (‘OpenAg’)

Arysta LifeScience Corporation is focused on helping the customers cultivate business growth through the development, marketing and distribution of innovative, high-quality chemical solutions for today’s dynamic agroscience and health & nutrition science marketplace. With a focus on emerging countries and niche markets, Arysta LifeScience manages a portfolio of more than 200 active ingredients. In addition to its Tokyo headquarters, the company maintains more than 40 offices and subsidiaries that serve 125 countries worldwide. Arysta LifeScience is backed by the strength of Industrial Equity Investments Limited (IEIL), an international investment company, owned by the leading private equity firm Permira.